Evidence map›Paper›PMID 17350876›Full record

ReviewThe international journal of biochemistry & cell biology2007

Src kinase signaling in leukaemia.

Shaoguang Li

Open access · greenAbstract readReview
In one paragraph

Review in The international journal of biochemistry & cell biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Heme controls the regulation of protein tyrosine kinases Jak2 and Src.Biochemical and biophysical research communications · 2010
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Shaoguang LiThe Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA. shaoguang.li@jax.org
Jackson Laboratory · US

Funding

Src Kinases in Ph+ Lymphoblastic LeukemiaR01CA114199 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LI, SHAOGUANG · 2005 to 2009
$1.4M
NCI NIH HHS R01 CA114199
6 · The paper itself

Abstract

Role of Src kinases in acute lymphoblastic leukaemia has been recently demonstrated in leukaemia mouse model. Retained activation of Src kinases by the BCR-ABL oncoprotein in leukaemic cells following inhibition of BCR-ABL kinase activity by imatinib indicates that Src activation by BCR-ABL is independent of BCR-ABL kinase activity and provides an explanation for reduced effectiveness of the BCR-ABL kinase activity inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Simultaneous inhibition of kinase activity of both BCR-ABL and Src kinases results in long-term survival of mice with acute lymphoblastic leukaemia. Leukaemic stem cells exist in acute lymphoblastic leukaemia, and complete eradication of this group of cells would provide a curative therapy for this disease.

Indexed as

Signal TransductionAnimalsAntineoplastic AgentsBenzamidesCell SurvivalEnzyme ActivationGene Expression Regulation, LeukemicGenes, ablHumansImatinib MesylateMiceNeoplastic Stem CellsPiperazinesPrecursor Cell Lymphoblastic Leukemia-LymphomaPyrimidinessrc-Family KinasesAntineoplastic AgentsBenzamidesImatinib MesylatePiperazinesPyrimidinessrc-Family Kinases

Identifiers

PMID17350876
PMCPMC2063586
OpenAlexW2017678741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.